Cyclosporin A


CAS No. : 59865-13-3

(Synonyms: Cyclosporine A; Ciclosporin A; CsA)

59865-13-3
Price and Availability of CAS No. : 59865-13-3
Size Price Stock
100mg $60 In-stock
200mg $84 In-stock
500mg $120 In-stock
1g $204 In-stock
5g $500 In-stock
10 g Get quote
50 g Get quote
We match the lowest price on market.

We offer a substantial discount on larger orders, please inquire via [email protected]

or Fax: (86)21-58955996

Inquiry for price and availability only. Please place your order via our email or fax.

Cat. No. : HY-B0579
M.Wt: 1202.61
Formula: C62H111N11O12
Purity: >98 %
Solubility: DMSO : 62.5 mg/mL (ultrasonic);Ethanol : 50 mg/mL (ultrasonic)
Introduction of 59865-13-3 :

Cyclosporin A (Cyclosporine A) is an immunosuppressant which binds to the cyclophilin and inhibits phosphatase activity of protein phosphatase 2B (PP2B/calcineurin) with an IC50 of 5 nM[3]. Cyclosporin A is a molecular glue, binds to cyclophilin and calcineurin, leading to inactivation of nuclear Factor of activated T Cells (NFAT) and a subsequent decrease in the immune response. Cyclosporin A also inhibits CD11a/CD18 adhesion[8][9]. IC50 & Target:IC50: 7 nM (calcineurin) In Vitro:Cyclosporin A is able to bind with the cyclophilin in T cells[1].
Cyclosporin A works by forming a Cyclophilin-Cyclosporin A complex to inhibit calcineurin[2].
Cyclosporin A inhibits calcineurin in stimulated cells with an IC50 value of 7 nM[3].
Cyclosporin A suppresses the nuclear translocation of NF-AT[4].
Cyclosporin A shows an effect on mitochondria via preventing the MTP from opening with an IC50 of 39 nM[5]. In Vivo:Note:
Please do not refer to only one article to determine the experimental conditions. It is recommended to determine the optimal experimental conditions (animal strain, age, dosage, frequency and cycle, detection time and indicators, etc.) through preliminary experiments before the formal experiment.

Cyclosporin A can be used to construct uremia models. In male Wistar rats (weighing 140-200 g, aged 5-6 weeks), the pharmacokinetic parameters following intravenous administration of Cyclosporin A (10 mg/kg) show an area under the curve of 27.3 μg·h/mL, a half-life of 6.9 hours, and a volume of distribution of 3.7 L/kg[9].

Induction of uraemia[10][11]
Background
Cyclosporin A administration induces interstitial deposition of collagen type III and fibrosis via stimulation of the Transforming Growth Factor beta (TGF-β)-signalling pathway, while inhibiting extracellular matrix (ECM) degradation via modulation of matrix metallopeptidase 9, thus leading to an imbalance in ECM turn over[2].
Specific Modeling Methods
Mice: Six-to-eight weeks old C57BL/6 mice
Administration: 30 mg/kg • SC • daily for 16 weeks
Note
Modeling Indicators
Molecular changes: Upregulated mRNA expression of both LOX, LOXL2, TNFα, MCP-1, (NOX)4; significantly downregulated SOD2 mRNA expression; increased the urea nitrogen (BUN) level, increased tubular injury, interstitial inflammation and fibrosis scores, PAS scores, increased the level the deposition of collagen type I (COL1) and type III (COL3) in the renal ECM,increased the expression of alpha-smooth-muscle actin (α-SMA), fibronectin (FN), COL1A, MCP-1[10][11].
Opposite Product(s): Lipoxygenase, general (HY-P2976); Anti-Mouse/Human/Rat/Monkey/Hamster/Canine/Bovine TGF-β Antibody (1D11) (HY-P990107)

Your information is safe with us.